Which companies are ABA Chemicals's closest peers?

The cockpit's peer set: CK Life Sciences International (Holdings) (0775.HK), Hangzhou Minsheng Healthcare (301507.SZ), ArriVent BioPharma (AVBP), Lanzhou Foci Pharmaceutical (002644.SZ), Hunan Hansen Pharmaceutical (002412.SZ), Lionco Pharmaceutical (603669.SS), Shanxi Zhendong Pharmaceutical (300158.SZ), Brother Enterprises (002562.SZ).

Is ABA Chemicals expensive compared with its peers?

On forward p/e it trades at 438.0× against a peer median of 24.2×, most expensive of 10 in its peer set.

How has ABA Chemicals stock performed?

Over six months to 6 Nov 2026 the shares returned -26.5% against -19.4% for the median peer; over one year -39.3%.

← CockpitCompetitor Analysis › 300261.SZ ABA Chemicals Corporation Class AOpen in the cockpit ↗

ABA Chemicals Corporation Class A300261.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Pharmaceuticals: Other

Momentum weak 27

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$641M

US dollars, full cap

Free float

62%

of shares outstanding

$/day

$4.93M

20-day average traded

Fwd P/E

438.0×

forward earnings

ROIC−WACC

-10.8 pp

WACC 7.3%

Hurdle

n/a

no reverse DCF

Next earnings

173 days

28 Apr 2027

Close · CNYCN¥4.38

1D-2.0%

1W+4.8%

1M-9.7%

3M-14.9%

6M-26.5%

YTD-34.9%

1Y-39.3%

ATR %3.7%

52w lowhigh49.4% off high

What ABA Chemicals does

Employees: 1,195

ABA Chemicals at a glance

Size ABA Chemicals (300261.SZ) is a China Health Care company (Pharmaceuticals: Other) with a market value of $641M, the 3262nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥4.38 on 6 Nov 2026.

Performance Over six months the shares fell 26.5%, against -19.4% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.

Growth Revenue fell 16.4% over the last twelve months (peer median +0.5%); the operating margin is -23.4% (peer median 9.5%).

Valuation It trades at 438.0× forward earnings against a peer median of 24.2× (most expensive of 10).

Capital Return on invested capital runs 10.8 points below its cost of capital (7.3% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

Six months, rebased to 100: ABA Chemicals against the median of its 20 peers (local-currency closes).

ABA Chemicals financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	CN¥1.05B	CN¥1.30B	CN¥1.20B	CN¥1.27B	CN¥1.99B
Revenue growth	—	+9%	-6%	-36%	—
Gross profit	CN¥138M	CN¥201M	CN¥146M	CN¥264M	CN¥571M
EBITDA	n/a	CN¥30.4M	-CN¥42.6M	CN¥71.4M	CN¥391M
Net income	-CN¥419M	-CN¥160M	-CN¥258M	-CN¥82.3M	CN¥203M
Free cash flow	-CN¥22.1M	-CN¥125M	CN¥58.5M	-CN¥256M	-CN¥107M
Capital expenditure	CN¥180M	CN¥129M	CN¥143M	CN¥232M	CN¥190M
Total debt	CN¥1.52B	CN¥1.33B	CN¥1.32B	CN¥1.23B	CN¥1.10B

Quarterly statements and history in the cockpit →

ABA Chemicals competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

Up and to the right = strong over both horizons. ABA Chemicals is the large dot.

Fundamentals: revenue growth against valuation

Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. ABA Chemicals is the large dot.

ABA Chemicals competitors and peer comparison

How ABA Chemicals compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

ABA Chemicals against its 20 peers (data as of 6 Nov 2026)
Measure	300261.SZ	Peer median	Rank in peer set
1-month return	-9.7%	-6.9%	9th lowest of 21
6-month return	-26.5%	-19.4%	7th lowest of 21
Distance from 52-week high	-49.4%	-37.2%	5th lowest of 21
Revenue growth (TTM)	-16.4%	+0.5%	3rd lowest of 20
Operating margin	-23.4%	9.5%	2nd lowest of 19
Forward P/E	438.0×	24.2×	most expensive of 10
ROIC minus cost of capital	-10.8 pp	-0.2 pp	2nd lowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	Forward P/E	Req g	Delivered g
ABA Chemicals 300261.SZ	China	$641M	-27%	-16%	-23%	438.0×	n/a	n/a
CK Life Sciences International (Holdings) 0775.HK	Hong Kong	$644M	-30%	0%	0%	n/a	n/a	n/a
Hangzhou Minsheng Healthcare 301507.SZ	China	$624M	-21%	+21%	11%	48.6×	20.4%	+12.1%
ArriVent BioPharma AVBP	United States	$673M	-54%	n/a	n/a	n/a	n/a	n/a
Lanzhou Foci Pharmaceutical 002644.SZ	China	$582M	-9%	+3%	5%	n/a	24.3%	+6.5%
Hunan Hansen Pharmaceutical 002412.SZ	China	$582M	+10%	-4%	21%	n/a	3.0%	+7.0%
Lionco Pharmaceutical 603669.SS	China	$581M	+21%	-6%	-17%	n/a	n/a	n/a
Shanxi Zhendong Pharmaceutical 300158.SZ	China	$713M	-16%	-28%	-25%	n/a	n/a	n/a
Brother Enterprises 002562.SZ	China	$716M	-28%	+8%	4%	n/a	4.9%	+13.5%
China Shineway Pharmaceutical 2877.HK	Hong Kong	$719M	-21%	-18%	25%	7.2×	n/a	n/a
Shanghai Kaibao Pharmaceutical 300039.SZ	China	$756M	-17%	-14%	22%	n/a	1.8%	+4.8%
Sirio Pharma 300791.SZ	China	$790M	-12%	-9%	1%	16.9×	14.7%	+15.6%
Tianjin Tianyao Pharmaceuticals 600488.SS	China	$801M	-14%	-12%	3%	n/a	3.6%	-1.3%
PharmaNutra PHN.MI	Italy	$808M	-18%	+18%	21%	29.6×	4.0%	+18.5%
Myung in Pharm 317450.KS	South Korea	$455M	-24%	+7%	35%	n/a	-14.7%	+8.9%
TSI 603262.SS	China	$909M	-41%	+3%	14%	51.5×	25.8%	+13.4%
Sihuan Pharmaceutical 0460.HK	Hong Kong	$952M	-35%	+30%	15%	9.7×	n/a	n/a
Tibet Aim Pharm 002826.SZ	China	$427M	-23%	+13%	14%	n/a	1.3%	+1.0%
New Journey Health Technology Group Co., Ltd.Class A 002219.SZ	China	$999M	-16%	-14%	8%	193.0×	n/a	n/a
Applied Nutrition APN.L	United Kingdom	$1.01B	+42%	+24%	n/a	24.2×	n/a	n/a
Boiron BOI.PA	France	$391M	-31%	-2%	5%	9.7×	-0.3%	-0.5%

Questions

Which companies are ABA Chemicals's closest peers?: The cockpit's peer set: CK Life Sciences International (Holdings) (0775.HK), Hangzhou Minsheng Healthcare (301507.SZ), ArriVent BioPharma (AVBP), Lanzhou Foci Pharmaceutical (002644.SZ), Hunan Hansen Pharmaceutical (002412.SZ), Lionco Pharmaceutical (603669.SS), Shanxi Zhendong Pharmaceutical (300158.SZ), Brother Enterprises (002562.SZ).
Is ABA Chemicals expensive compared with its peers?: On forward p/e it trades at 438.0× against a peer median of 24.2×, most expensive of 10 in its peer set.
How has ABA Chemicals stock performed?: Over six months to 6 Nov 2026 the shares returned -26.5% against -19.4% for the median peer; over one year -39.3%.